Masaki Hara (Tokyo Dialysis Frontier Group)

Educational Background & Professional Career
Name	Masaki Hara
Country	Japan
Affiliation	Tokyo Dialysis Frontier Group
Department	Internal Medicine-Nephrology
M.D., Ph.D. Nephrologist specializing in dialysis therapy and home hemodialysis Director, Tokyo Dialysis Frontier Group, Japan Secretary General, Japanese Society for Home Hemodialysis (JSHHD)
Research Interests
Home hemodialysis (HHD) and patient-centered dialysis care Indication-based and individualized dialysis strategies, including extended-hour and intensive dialysis Integrated dialysis models, particularly PD–HHD transition Implementation and scalability of home dialysis systems
Publications
Hara M, et al. Atazanavir nephrotoxicity. Clin Kidney J. 2015. Hara M, et al. Increased non-HDL-C level linked with a rapid rate of renal function decline in HIV-infected patients. Clin Exp Nephrol. 2017. Hara M, et al. The renal pathological findings in Japanese HIV-infected individuals with CKD: a clinical case series from a single center. Clin Exp Nephrol. 2018. Ubukata M, Hara M, et al. Prevalence and mortality of chronic kidney disease in lymphoma patients: a large retrospective cohort study. Medicine (Baltimore). 2018. Hara M, et al. A case of IgA nephropathy associated with mycosis fungoides that developed into rapidly progressive glomerulonephritis. Clin Nephrol. 2013.